Maha FDA Seeks To File FIR In Mayo Sting Op After 12 Days

Nagpur : In a fresh twist, the Food and Drugs Administration (FDA) woke up from its slumber on Tuesday to reach Tehsil police station to file a fresh FIR in the Mayo sting operation case, in which police have already booked the offenders and arrested them too on February 22.

Police refused to file a second FIR in the same matter. On February 16, police had written a letter to FDA, followed by another this week, but the drug regulatory authority had so far refused to file FIR, before its turnaround on Tuesday.

Zonal DCP Gorakh Bhamre said police had repeatedly sought a complaint from FDA, which they had been refusing so far. “We will now add their complaint and issues in our evidence to make the case stronger. But, police could have got custody remand of the pharmacist and the trespasser had FDA lodged the complaint earlier,” said Bhamre. TOI too had highlighted how police were denied remand custody by the court as FDA did not file their complaint.

Mayo hospital authorities too have not filed their internal committee report as of now.

In the meanwhile, three different drug licenses of the concerned pharmacist have now come to fore, making the illegal drug selling case in Mayo hospital more murky. The FDA, which may file a police complaint regarding this, is itself under the scanner now.

Sources said the pharmacist had surrendered one license, and procured a second one immediately from FDA under the Drugs and Cosmetics Act. The pharmacist is also in possession of yet another license in the name of his father.

FDA, along with police, had visited the pharmacy at Pardi on February 15 after chemists nabbed Sumeet Sonulkar illegally selling and supplying medicines in ward number 44 of surgical complex at Mayo Hospital. The cops and FDA had returned empty handed from the pharmacy and allowed pharmacist Rakesh Khandare to produce documents on the following day, which made the police case against him weak.

  • Related Posts

    • Pharma
    • July 26, 2024
    • 128 views
    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    Maryland: The US Food and Drug Administration (FDA) has warned Brassica Pharma for numerous good manufacturing practice (GMP) violations, including multiple instances of employees falsifying sterility and environmental monitoring data and…

    • Pharma
    • July 26, 2024
    • 125 views
    Indian National Charged With Selling Counterfeit Cancer Drugs

    HOUSTON: A federal grand jury has returned an indictment charging an Indian national with selling and shipping tens of thousands of dollars in counterfeit oncology pharmaceuticals into the United States,…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    US FDA Finds Data Integrity, Sterility Problems At Brassica Pharma

    Indian National Charged With Selling Counterfeit Cancer Drugs

    Indian National Charged With Selling Counterfeit Cancer Drugs

    ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

    ICMR Releases 32 New Treatment Standards For Treating Common And Serious Diseases

    BIS Sanctioned 82 Medical Device Projects To Develop Standards

    BIS Sanctioned 82 Medical Device Projects To Develop Standards

    Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

    Anti-Narcotics Task Force Will Be Formed Soon In Rajasthan: HM

    ‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD

    ‘Sunrise’ MedTech Industry in India & ‘Clouds’ strangling it, Brainstormed in PHD